mutLBSgeneDB |
Gene summary for RNF31 |
Gene summary |
Basic gene Info. | Gene symbol | RNF31 |
Gene name | ring finger protein 31 | |
Synonyms | HOIP|ZIBRA | |
Cytomap | UCSC genome browser: 14q11.2 | |
Type of gene | protein-coding | |
RefGenes | NM_017999.4, | |
Description | E3 ubiquitin-protein ligase RNF31HOIL-1-interacting proteinzinc in-between-RING-finger ubiquitin-associated domain protein | |
Modification date | 20141207 | |
dbXrefs | MIM : 612487 | |
HGNC : HGNC | ||
Ensembl : ENSG00000092098 | ||
HPRD : 11516 | ||
Vega : OTTHUMG00000028798 | ||
Protein | UniProt: Q96EP0 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RNF31 | |
BioGPS: 55072 | ||
Pathway | NCI Pathway Interaction Database: RNF31 | |
KEGG: RNF31 | ||
REACTOME: RNF31 | ||
Pathway Commons: RNF31 | ||
Context | iHOP: RNF31 | |
ligand binding site mutation search in PubMed: RNF31 | ||
UCL Cancer Institute: RNF31 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0000209 | protein polyubiquitination | 12629548 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 19136968 | GO:0050852 | T cell receptor signaling pathway | 20005846 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 19136968 | GO:0097039 | protein linear polyubiquitination | 21455173 |
Top |
Ligand binding site mutations for RNF31 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | H836 | R837Q | COAD | 1 | H923 | S921Y | GBM | 1 | C890 | T891S | LUSC | 1 | C817 | P818L | SKCM | 1 | C911 | K910I | STAD | 1 | G97 | G97S | UCEC | 1 | C986 | A985V | UCEC | 1 | H923,H925 | G924S | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for RNF31 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C890 | T891S | -1.1620088 | C986 | A985V | -1.0786427 | H923 | G924S | -0.80579729 | H925 | G924S | -0.80579729 | G97 | G97S | -0.69201264 | H923 | S921Y | -0.64035281 | H836 | R837Q | -0.39219003 | C911 | K910I | -0.24856136 | C817 | P818L | -0.21526133 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for RNF31 from PDB |
Top |
Differential gene expression and gene-gene network for RNF31 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for RNF31 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for RNF31 |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of RNF31 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ZN | ZINC(2+) | 4ljo | A | C890 | ZN | ZINC(2+) | 4ljp | A | C890 | ZN | ZINC(2+) | 4ljq | B | C890 | ZN | ZINC(2+) | 4ljq | A | C890 | ZN | ZINC(2+) | 4ljq | C | C890 | ZN | ZINC(2+) | 4ljq | D | C890 | ZN | ZINC(2+) | 4ljo | A | C911 H923 H925 | ZN | ZINC(2+) | 4ljp | A | C911 H923 H925 | ZN | ZINC(2+) | 4ljq | B | C911 H923 H925 | ZN | ZINC(2+) | 4ljq | A | C911 H923 H925 | ZN | ZINC(2+) | 4ljq | C | C911 H923 H925 | ZN | ZINC(2+) | 4ljq | D | C911 H923 H925 | ZN | ZINC(2+) | 4ljo | A | C986 | ZN | ZINC(2+) | 4ljp | A | C986 | ZN | ZINC(2+) | 4ljq | B | C986 | ZN | ZINC(2+) | 4ljq | A | C986 | ZN | ZINC(2+) | 4ljq | C | C986 | ZN | ZINC(2+) | 4ljq | D | C986 | III | Peptide ligand (ASP,LEU,TYR,GLY) | 4p0a | A | G97 | III | Peptide ligand (ASP,MET,TYR,ARG) | 4p0b | A | G97 | III | Peptide ligand (ASP,MET,TYR,ARG) | 4p0b | C | G97 | III | Peptide ligand (GLU,ASP,MET,TYR,ARG,ALA,ALA,ASP,GLU,ILE,GLU,LYS,GLU) | 4oyk | A | G97 | III | Peptide ligand (GLU,ASP,MET,TYR,ARG,ALA,ALA,ASP,GLU,ILE,GLU,LYS,GLU,LYS,GLU) | 4oyk | B | G97 |
Top |
Conservation information for LBS of RNF31 |
Multiple alignments for Q96EP0 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |